bioMérieux S.A. (EPA:BIM)
71.60
-0.25 (-0.35%)
Jul 31, 2026, 10:17 AM CET
bioMérieux Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, bioMérieux stock has a consensus rating of "Hold" and an average price target of €79.04. The average 1-year stock price forecast is 10.39% higher than the current stock price, while the lowest is €64.00 (-10.61%) and the highest is €100.00 (+39.66%).
Price Target: €79.04 (+10.39%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for bioMérieux stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 7 | 8 | 9 | 8 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 13 | 13 | 13 | 12 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold Maintains €78.00 → €75.00 | Hold | Maintains | €78.00 → €75.00 | +4.75% | Jul 30, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates €80.00 | Hold | Reiterates | €80.00 | +11.73% | Jul 29, 2026 |
| UBS | UBS | Hold Maintains €80.00 → €78.00 | Hold | Maintains | €80.00 → €78.00 | +8.94% | Jul 29, 2026 |
| Kepler Capital | Kepler Capital | Buy Maintains €85.00 | Buy | Maintains | €85.00 | +18.72% | Jun 25, 2026 |
| Morgan Stanley | Morgan Stanley | Sell Downgrades €100.00 → €64.00 | Sell | Downgrades | €100.00 → €64.00 | -10.61% | Jun 23, 2026 |
Financial Forecast
Revenue This Year
4.12B
from 4.07B
Increased by 1.34%
Revenue Next Year
4.34B
from 4.12B
Increased by 5.17%
EPS This Year
4.34
from 4.64
Decreased by -6.43%
EPS Next Year
4.66
from 4.34
Increased by 7.44%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.